Pipeline Assessment on Point-of-Care (POC) Analyzers Covering Information on Ongoing Pipeline Products and Clinical Trials in 2017

Posted on 2017-09-22 by Mark Hub in Pharmaceuticals // 0 Comments

MARKET RESEARCH HUB

Albany, US, 2017-Sep-22 — /EPR Network/ —In the recent years, device manufacturers have been making continuous progress in terms of research and development to come up with newer and more advanced products and technologies. Point-of-care analyzers are such an innovation which is carried out in the clinics, home or near patient locations for testing of a sample from a patient in order to facilitate prompt clinical decisions regarding patient management. It has been analyzed that the point-of-care diagnostics market is gaining a significant boost from the growing prevalence of infectious diseases across the world. To identify future growth prospects in this rapidly growing market, a new pipeline study titled “Point-of-Care (POC) Analyzers – Medical Devices Pipeline Assessment, 2017” has been released and added to the vast storehouse of Market Research Hub (MRH). This study presents comprehensive outlook of the point-of-care analyzers market and provides information on the pipeline products with comparative analysis of the products at various stages of development.

Request free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1326349

Point-of-Care (POC) analyzers are minor size, tabletop/bench top analyzer that uses a laser diode to detect fluorescence/Chemiluminescence for the quantitative detection of biomolecules such as specific proteins, hormones, antibodies to infectious diseases and therapeutic drugs. The point-of-care series includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening and diagnosis of patients as well as rapid tests for pregnancy and common infectious diseases. At present, private investments and venture funding towards the development of new products along with the growing government support to increase the adoption of POC devices are boosting market growth.

This study includes extensive coverage of the point-of-care analyzers under development. In addition to this, it also provides information about clinical trials that are currently in progress, which includes trial phase, trial status, trial start & end dates, and the number of trials for the point-of-care analyzers pipeline products. The coverage of pipeline products based on various stages of advancement ranging from early development to approved/issued stage. In order to provide clear vision of the market, this study has been built using proprietary databases along with latest updates and featured news & press releases from various university sites and industry-specific third party sources.

Browse Full Report With TOC: http://www.marketresearchhub.com/report/point-of-care-poc-analyzers-medical-devices-pipeline-assessment-2017-report.html

Furthermore, the study identifies evolving players with theoretically strong product portfolio and create effective counter-strategies to gain competitive advantage. This competitive landscape section gives a explanation of the competitive nature of the market, market shares and a description of the leading companies. Companies covered in this point-of-care analyzers market pipeline report include Akers Biosciences Inc., Akonni Biosystems Inc., Analytical Diagnostic Solutions Inc., Alere Inc., Aquila Diagnostic Systems Inc., Bio-Alternative Medical Devices Ltd, Boston University, BioMedomics Inc., CardioGenics Inc., ChipCare Corp Company, Co-Diagnostics HBDC, Inc., Exosome Diagnostics, Inc., McKesson Corp., Magna Diagnostics GmbH, Radisens Diagnostics Ltd. and others.

Enquire About this Report: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1326349

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of reports and analysis. MRH’s expansive collection of medical equipments industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick